Multi-Channel Automated Diet and Physical Activity Intervention for Pre-Diabetics

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01479062

Recruitment Status : Completed

First Posted : November 24, 2011

Last Update Posted : January 18, 2018

Sponsor:

Collaborator:

Palo Alto Medical Foundation

Information provided by (Responsible Party):

Gladys Block, Berkeley Analytics, Inc.

Study Description

Brief Summary:

The trial will test whether the Alive multi-channel delivery health behavior program can positively affect weight and glucose level in pre-diabetics.

Condition or disease	Intervention/treatment	Phase
Pre-diabetes Diabetes Obesity	Behavioral: Alive-PD Behavioral: Usual Care	Not Applicable

Study Design


Study Type :	Interventional (Clinical Trial)
Actual Enrollment :	339 participants
Allocation:	Randomized
Intervention Model:	Parallel Assignment
Masking:	Single (Outcomes Assessor)
Primary Purpose:	Prevention
Official Title:	Multi-Channel Automated Diet and Physical Activity Intervention for Pre-Diabetics (ALIVE-PD)
Study Start Date :	February 2014
Actual Primary Completion Date :	June 2015
Actual Study Completion Date :	December 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Exercise and Physical Fitness Health Checkup Prediabetes

U.S. FDA Resources

Arms and Interventions

Arm	Intervention/treatment
Experimental: participation in Alive-PD Alive-PD lifestyle intervention with multi-channel delivery	Behavioral: Alive-PD Weekly email/web goal-setting intervention to improve physical activity, diet and weight loss for pre-diabetics, with additional phone support
Placebo Comparator: Control Usual care	Behavioral: Usual Care Placebo Control

Outcome Measures

Primary Outcome Measures :

Change from baseline in body weight [ Time Frame: at 3 months, 6 months and one year ]
Mean weight loss and the proportion of subjects who achieve a 5% body weight loss at 3 and 6 months and maintain at 12 months
Change from baseline in diabetes risk markers [ Time Frame: at 3 months, 6 months and one year ]
Change in blood glucose level and hemoglobin A1c (HbA1c) as measured in clinic at 3 and 6 months and maintain at 12 months

Secondary Outcome Measures :

Change from baseline in physical activity and dietary factors [ Time Frame: 3 months and 12 months ]
Extent of change in physical activity and dietary factors as reported in questionnaires

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:	40 Years to 79 Years (Adult, Older Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

at least one measurement in past 2 yrs of fasting plasma glucose of 100-125 mg/dl or impaired glucose tolerance
at least one measurement of body mass index (BMI) >=27 in the past two years
age 40-79
no use of diabetes medications within the past two years
member of Kaiser Permanente of Northern California (KPNC) for at least 2 years
live in a 25 mile radius of the KPNC Research Clinic in Oakland, CA

Exclusion Criteria:

comorbidities that would contraindicate the gradual adoption of light/moderate physical activity, such as a recent cardiovascular event, severe chronic obstructive pulmonary disease, advanced arthritis, or poorly controlled hypertension

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01479062

Locations


United States, California
Palo Alto Medical Foundation Research Institute
Palo Alto, California, United States, 94301

Sponsors and Collaborators

Berkeley Analytics, Inc.

Palo Alto Medical Foundation

Investigators


Principal Investigator:	Gladys Block, PhD	Berkeley Analytics, Inc.

More Information

Publications of Results:

Block G, Azar KM, Romanelli RJ, Block TJ, Hopkins D, Carpenter HA, Dolginsky MS, Hudes ML, Palaniappan LP, Block CH. Diabetes Prevention and Weight Loss with a Fully Automated Behavioral Intervention by Email, Web, and Mobile Phone: A Randomized Controlled Trial Among Persons with Prediabetes. J Med Internet Res. 2015 Oct 23;17(10):e240. doi: 10.2196/jmir.4897.

Other Publications:

Block G, Azar KM, Block TJ, Romanelli RJ, Carpenter H, Hopkins D, Palaniappan L, Block CH. A Fully Automated Diabetes Prevention Program, Alive-PD: Program Design and Randomized Controlled Trial Protocol. JMIR Res Protoc. 2015 Jan 21;4(1):e3. doi: 10.2196/resprot.4046.


Responsible Party:	Gladys Block, Principal Investigator, Berkeley Analytics, Inc.
ClinicalTrials.gov Identifier:	NCT01479062 History of Changes
Other Study ID Numbers:	1R44NR012617-01 ( U.S. NIH Grant/Contract )
First Posted:	November 24, 2011 Key Record Dates
Last Update Posted:	January 18, 2018
Last Verified:	July 2016

Keywords provided by Gladys Block, Berkeley Analytics, Inc.:


behavior change pre-diabetes prevention diabetes prevention Hemoglobin A1c glucose	physical activity nutrition email web obesity

Additional relevant MeSH terms:


Diabetes Mellitus Prediabetic State Glucose Intolerance Glucose Metabolism Disorders	Metabolic Diseases Endocrine System Diseases Hyperglycemia

To Top